New evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease, according to a systematic review of published studies.

Peter Ahnesorg, Global Hematology Franchise Head, Roche, talks about his background in biochemistry, his hopes for the haematology space and his approach to leadership.

Discover the past and future of hematology. Uncover the challenges, advancements, and the industry’s commitment to patient well-being.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is estimated to affect approximately 300,000 individuals worldwide…

Salvage therapies have been identified in a new US study that could help patients with multiple myeloma, who have tried chimeric antigen receptor T-cell therapy that has been unsuccessful.

A recent study, revealing that the heightened risk of blood clots associated with hormonal contraceptives significantly diminishes after discontinuation, provides precise guidance on optimal contraceptive cessation timing.

This review article aims to provide an overview of platelet-rich plasma’s applications and evidence over the past 5 years in randomised…

A new study suggested that patients with inflammatory bowel disease could have an increased risk of contracting respiratory syncytial virus and may be eligible to receive RSV vaccines.